Tarik Sammour

Surgery — Royal Adelaide Hospital, Australia

LeadR Profile

Tarik Sammour Royal Adelaide Hospital Australia
1 035 ScienceLeadR Reputation 1035
Network Map

Surgery

Subspecialties: Oncology - Gastroenterology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2006 - 2026

Source: PubMed

Royal Adelaide Hospital

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 315

Citations

Citations: 7 325 1st author: 53 Last author: 94 Unique author: 9


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Four-Year Survival Outcomes of Personalized Total Neoadjuvant Therapy Versus Chemotherapy During the 'Wait Period' Versus Standard Chemoradiotherapy for Locally Advanced Rectal Cancer.
neoplasms, drug therapy, gastrointestinal neoplasms, chemoradiotherapy, neoadjuvant therapy, rectal neoplasms, therapeutics, chemotherapy
J Gastrointest Cancer20260
Evaluating quality of colorectal cancer surgery across elective and emergency health systems: secondary analysis of prospective cohort studies in 95 countries.
global health, emergencies, surgical procedures, operative, neoplasms, income, cohort studies, colorectal neoplasms
BJS Open20260
International validation of the Locally Recurrent Rectal Cancer-Quality of Life (LRRC-QoL) patient reported outcome measure.
quality of life, neoplasms, rectal neoplasms, patient reported outcome measures, therapeutics
EClinicalMedicine20260
Impact of RAS/RAF Mutations on Metastatic Treatment Response Following Total Neoadjuvant Therapy in Patients With Stage IV Rectal Cancer.
genes, ras, neoplasms, neoadjuvant therapy, rectal neoplasms, therapeutics, mutation
Asia Pac J Clin Oncol20260
Oral oxycodone versus sublingual buprenorphine for postoperative pain control after pelvic exenteration (PROSPER): a pilot, registry-embedded, multi-centre, double-blind, placebo-controlled, randomised controlled trial.
registries, buprenorphine, pilots, pelvic exenteration, pain, oxycodone, multiple chronic conditions, analgesia, pain, postoperative
BMJ Open20260

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 9
Phase 1 1

By status:

Completed 4
Recruiting 3
Unknown 2
Enrolling by invitation 1

By type:

Interventional 5
Observational 5

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 3
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 24

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
PRIORITY CONNECT 2 Trial
NCT06976710 — exercise, sample size, psychology, muscles, malnutrition, pain, caregivers, nursing, neoplasms, preoperative exercise, rehabilitation, risk management, telerehabilitation, proctocolectomy, restorative, smoking cessation, rectal neoplasms, muscle strength, colorectal neoplasms, education, respiratory muscles, smoking, alcohol drinking, colectomy, postoperative complications, surgeons
N/ARecruiting2025
PRIORITY CONNECT 2 Pilot Trial
NCT06212700 — exercise, comorbidity, pilots, pancreatic neoplasms, psychology, muscles, malnutrition, pain, caregivers, nursing, neoplasms, preoperative exercise, liver, gastrointestinal neoplasms, pancreas, liver neoplasms, smoking cessation, muscle strength, walking, colorectal neoplasms, education, respiratory muscles, smoking, alcohol drinking, stomach neoplasms, postoperative complications
N/ARecruiting2024
PelvEx Beating the Empty Pelvis Syndrome
NCT05683795 — pelvic exenteration, neoplasms, rectal neoplasms, pelvic neoplasms, postoperative complications
N/AEnrolling by invitation2023

LeadR Networks

Main global connection map